Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients

Abstract Background Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall prognosis of AIH is unknown, and treatment has not been established. Aim To investigate the risk factors and prognosis of HCC in...

Full description

Bibliographic Details
Main Authors: Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Tsutomu Masaki
Format: Article
Language:English
Published: BMC 2024-04-01
Series:BMC Gastroenterology
Subjects:
Autoimmune hepatitis
Hepatocellular carcinoma
Molecular-targeted drug
Immune checkpoint inhibitor
Carcinogenic factor
Online Access:https://doi.org/10.1186/s12876-024-03204-z

Similar Items

Similar Items